← Leaderboards
David Martin Gau
University Of Pittsburgh At Pittsburgh
$750,094
Attributed
$750,094
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2022–25$250K$187.5K$125K$62.5K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$750,094 · 2
By mechanism
R00$498,000 · 1
K99$252,094 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Partha Roy$5,696,734
- Panagiotis V Benos$14,018,248
- David Ryan Koes$4,131,008
- Joseph C. Glorioso$19,383,290
- James D Luketich$2,960,577
Others in their field
Other Rising Stars on “Extracellular”
- George Gaitanaris · Omeros Corporation$6,689,019
- Justin Lee Grodin · Ut Southwestern Medical Center$3,560,217
- Timothy I Richardson · Indiana University Indianapolis$3,206,036
- Yanhong Guo · University Of Michigan At Ann Arbor$3,191,698
- Daniel Paech · Brigham And Women'S Hospital$3,155,815
- Jeffrey B Ware · University Of Pennsylvania$3,116,729
Research focus
ExtracellularGlycolysisActinsEndotheliumGeneticAdvanced DiseaseAntagonistAffectAgonistAutophagocytosisActin-Binding ProteinBioenergeticsBiological ProcessBiologyBlood VesselsCell MotilityCell ProliferationAttenuatedAutomobile DrivingCessation Of LifeClear Cell Renal Cell CarcinomaCytoskeletonAngiogenesisGrowth
Grant awards (4)
Profilin as a Novel Target for Vascular Normalization in Renal Cancer$249,000
R00 · FY2025 · CA · contact PI
Profilin as a Novel Target for Vascular Normalization in Renal Cancer$249,000
R00 · FY2024 · CA · contact PI
Profilin as a Novel Target for Vascular Normalization in Renal Cancer$126,047
K99 · FY2023 · CA · contact PI
Profilin as a Novel Target for Vascular Normalization in Renal Cancer$126,047
K99 · FY2022 · CA · contact PI